After 400% Surge, Should Investors Care About Monte Rosa Insider Sale?
A biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
Understanding value investing principles is crucial for success. Get clear explanations to strengthen your investment knowledge.
20,239 articlesA biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
As AI workloads push data-center networks to the limit, Ciena could be uniquely positioned to turn a hidden opportuni...
The FBI director disclosed a late Strategy stock purchase, prompting questions about STOCK Act timing and potential c...
A new poll finds a prevailing mood that founders would be disappointed by modern democracy. This sentiment is shaping...
Savers chasing steady monthly income must quantify capital needs across three risk levels. A July 2026 snapshot shows...
Analysts warn AI could disrupt millions of jobs, prompting a national rethink of high school and workforce training. ...
Rising defense budgets are reshaping the investing landscape. This guide explains why two big players may benefit and...
Investors weigh COPX, the copper miners ETF, against CPER, a copper futures fund, as EV and grid investments push cop...
Two powerhouse ideas could propel your portfolio toward the next decade: a campus-wide AI infrastructure leader and a...
EU DAC8 and UK CARF rules are now driving tax reporting for 2027. As providers capture 2026 activity, investors shoul...
Global X's RYLD, a Russell 2000 covered-call ETF, underperforms uncapped peers this year as small-cap volatility ease...
Investing in eVTOLs isn’t just about flight tech. The real lever could be charging infrastructure. This guide explain...